IVVD
Invivyd Inc.
NASDAQ: IVVD · HEALTHCARE · BIOTECHNOLOGY
$1.40
+2.94% today
Updated 2026-04-30
Market cap
$412.89M
P/E ratio
—
P/S ratio
7.73x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $3
Volume
2.8M
Invivyd Inc. (IVVD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $25.38M | $53.43M |
| Revenue growth (YoY) | — | — | — | — | — | +110.5% |
| Cost of revenue | — | $1000.00 | $462000.00 | $2.03M | $1.62M | $3.75M |
| Gross profit | — | $-1000.00 | $-462000.00 | $-2.03M | $23.77M | $49.68M |
| Gross margin | — | — | — | — | 93.6% | 93.0% |
| R&D | $106.49M | $182.89M | $179.21M | $158.66M | $137.25M | $38.31M |
| SG&A | — | $36.52M | $47.04M | $49.13M | $63.39M | $66.93M |
| Operating income | $-111.99M | $-226.91M | $-248.03M | $-212.76M | $-176.88M | $-55.56M |
| Operating margin | — | — | — | — | -696.8% | -104.0% |
| EBITDA | $-65.33M | $-219.41M | $-225.80M | $-205.75M | $-173.76M | $-53.45M |
| EBITDA margin | — | — | — | — | -684.5% | -100.1% |
| EBIT | $-108.53M | $-219.41M | $-226.26M | $-207.78M | $-176.88M | $-55.56M |
| Interest expense | — | $15.00M | $43.08M | — | — | — |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-111.98M | $-226.79M | $-241.32M | $-198.64M | $-169.93M | $-52.49M |
| Net income growth (YoY) | — | -102.5% | -6.4% | +17.7% | +14.5% | +69.1% |
| Profit margin | — | — | — | — | -669.4% | -98.2% |